JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
16 * Sun, 8/9/2015, 2:00 PM - 3:50 PM CC-611
Exploring Bayesian Approaches in Drug Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section , Section on Bayesian Statistical Science , International Society for Bayesian Analysis (ISBA) , International Chinese Statistical Association , Biometrics Section
Organizer(s): Freda Cooner, FDA/CDER
Chair(s): Kathleen Fritsch, FDA
2:05 PM Bayesian Adaptive Commensurate Prior Methods for Rare Disease and Pediatric Clinical Trials — Bradley P. Carlin, University of Minnesota ; Cynthia Basu, University of Minnesota ; Brian Hobbs, MD Anderson Cancer Center
2:25 PM The Role of Simulation in Designing Rare Disease Trials — Jason Connor, Berry Consultants
2:45 PM Bayesian Approaches for Benefit-Risk Assessment — Ram Tiwari, FDA/CDER/OT/OB
3:05 PM Bayesian Opportunities in Clinical Trials from an Industry Perspective — Fanni Natanegara, Eli Lilly and Company ; Karen Price, Eli Lilly and Company
3:25 PM Discussant: Freda Cooner, FDA/CDER
3:45 PM Floor Discussion




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home